E-slide Library

IBD Insights from United European Gastroenterology Week 2015: A faculty roundtable discussion


Jean-Frédéric Colombel, MD (Course Director)
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System
New York, NY


Flemming Bendtsen, MD
Professor and Chief Physician
Department of Gastroenterology
University of Copenhagen
Hvidovre Hospital


Marco Daperno, MD
Consultant Gastroenterologist
Gastroenterology Unit
Mauriziano Hospital
Turin, Italy


James Lindsay, PhD, FRCP
Consultant Gastroenterologist
Bart's Health NHS Trust
Reader in Inflammatory Bowel Disease
Centre for Immunobiology
Blizard Institute
Queen Mary University of London
London, United Kingdom



This IBD Dialog will discuss some of the key highlights and insights from United European Gastroenterology Week (UEGW) 2015, held in Barcelona, Spain. This IBD Dialog, in the format of a Faculty Roundtable discussion, will offer a clinically focused update on some of the important information presented during UEGW, as selected by our faculty. The activity will provide you with an insight into some of the key clinical data allowing you to implement new understanding into your own practice

This activity has been designed to meet the educational needs of gastroenterologists and registered nurses involved in the care of patients with inflammatory bowel disease (IBD).

Release date: December 1, 2015

Learning objectives

After completing this activity, the participant should be better able to:

  • Summarize data related to Crohn's disease (CD) and ulcerative colitis (UC) presented at United European Gastroenterology Week 2015
  • Consider how the data presented may affect clinical practice
  • Evaluate the new data on emerging therapies for IBD
  • Provide appropriate care and counsel for patients and their families.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

View Presentation